Pyrroloquinoline derivatives and their use as protein kinases inhibitors
US8426437B2 · kind B2 · utility
3Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2006 |
| Grant date | Apr 23, 2013 |
| Priority date | — |
| Expiry date | Jun 1, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of protein kinases of formula I:which can be used in the treatment of various diseases, notably cancer, inflammation or disorders of the central nervous system. It also relates to pharmaceutical compositions containing the compounds according to the invention and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.